Jana Fassunke

7PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

|Dec 19, 2025
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Felix John, Lea Ruge, Malte Verheyen

|Feb 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastoma.

Carolina Rosswog, Jana Fassunke, Angela Ernst

|Oct 14, 2022
Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD).

Thilo Bracht, Daniel Kleefisch, Karin Schork

|Sep 23, 2020
Combining biopsy tools improves mutation detection rate in central lung cancer.

Lars Hagmeyer, Stephan Schäfer, Marianne Engels

Pageof 2